See LEGEND for key to shading and symbols.
:: Subject Area - PHAR Term - Semester 1
| PHAR3102 | PHAR3111 | PHAR3251 | PHAR9101 | PHAR9113 | PHAR9114 |
| PHAR9116 | PHAR9118 | PHAR9122 | PHAR9124 |
Data is correct as at Thu 6 Sep 19:04:45 AEST 2018
| Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
| PHAR3102 | Molecular Pharmacology | ||||||
| LAB | H10A | 6704 | Enr | Open* | 34/36 | 94% | Thu 10-13 (Wurth 120) |
| LAB | H14A | 6705 | Enr | Open | 29/34 | 85% | Thu 14-17 (Wurth 120) |
| LEC | A | 6703 | Rel | Open | 63/70 | 90% | Wed 09 (w1-5,6-7,9-13, CLB 3); Fri 15 (w1-4,6-13, Vall 121) |
| TUT | W11A | 6706 | Rel | Full | 35/35 | 100% | Wed 11 (w1-5,6-7,9-13, Mat 230) |
| TUT | W13A | 6707 | Rel | Open | 28/35 | 80% | Wed 13 (w1-5,6-7,9-13, Mat 232) |
| PHAR3111 | Clinical Pharmacology for HESC | ||||||
| LAB | M13A | 8971 | Rel | Open | 93/100 | 93% | Mon 13-16 (w1,3,5,7,9-11, Wurth 115) |
| LE1 | A | 8969 | Rel | Open | 93/100 | 93% | Fri 14-16 (w1-4, Ainswth202); Fri 14-16 (w6-13, Ainswth202) |
| LE2 | B | 8970 | Auto | Open | 93/100 | 93% | Thu 09 (w1-5,6,8,10,12, WurthLG03) |
| TUT | T14A | 8972 | Enr | Open | 48/50 | 96% | Tue 14 (w2,4,6,8,10,12, Mat 309) |
| TUT | T15A | 8973 | Enr | Open | 45/50 | 90% | Tue 15 (w2,4,6,8,10,12, Mat 309) |
| PHAR3251 | Clinical & Exp'l Pharmacology | ||||||
| LAB | M09A | 3780 | Enr | Open | 72/76 | 95% | Mon 09-12 (Wurth 115) |
| LEC | A | 3779 | Rel | Open | 72/76 | 95% | Mon 17 (CLB 3); Thu 13 (MathewsThD) |
| TUT | M13A | 3781 | Rel | Open | 35/38 | 92% | Mon 13 (w2-5,6-13, Mat 102) |
| TUT | M15A | 3782 | Rel | Open | 37/38 | 97% | Mon 15 (w2-5,6-13, Mat 102) |
| PHAR9101 | Intro to Therapeutics Industry | ||||||
| DST | 1 | 10072 | Enr | Open | 21/30 | 70% | |
| PHAR9113 | InternationalRegulatoryAffairs | ||||||
| DST | 1 | 10073 | Enr | Open | 7/30 | 23% | |
| PHAR9114 | HTA in Australia | ||||||
| DST | 1 | 10074 | Enr | Open | 17/30 | 57% | |
| PHAR9116 | Clinical Trial Management | ||||||
| DST | 1 | 10075 | Enr | Open | 8/30 | 27% | |
| PHAR9118 | Therapeutics | ||||||
| DST | 1 | 10076 | Enr | Open | 5/30 | 17% | |
| PHAR9122 | Medical Affairs | ||||||
| DST | 1 | 10077 | Enr | Open | 22/30 | 73% | |
| PHAR9124 | Internship | ||||||
| DST | 1 | 10078 | Enr | Open* | 0/5 | 0% | |
| ^ top ^ | |||||||
| LEGEND | |||||||
| * This class requires consent. Students cannot self-enrol. | |||||||
| # Timetable clash allowed. | |||||||
| /odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
| Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
| Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
| [ ] Class capacity where different from effective capacity. | |||||||
| Shaded cells: | LEC | Activity different from previous | |||||
| Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
| 100% | Class is full (> 100% means capacity is exceeded) | ||||||
| 80% | Class is nearly full (80% or more) | ||||||
| 50% | Class is half full | ||||||
| 0% | Class is less than half full | ||||||
| UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G • Authorised by Deputy Vice Chancellor (Academic) & Registrar • Privacy Statement • Copyright & Disclaimer |